![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JM Peters, YC Zhou, PA Ram, SS Lee, FJ Gonzalez and DJ Waxman
Laboratory of Molecular Carcinogenesis, National Cancer institute, National Institutes of health, Bethesda, Maryland 20892, USA.
Peroxisome proliferator-activated receptor alpha (PPAR alpha) mediates the effects of foreign chemical peroxisome proliferators on liver and kidney, including the induction of peroxisomal, mitochondrial, and microsomal enzymes involved in beta-oxidation of fatty acids. However, the role of this receptor in the peroxisome proliferative effects of the endogenous steroid dehydroepiandrosterone (DHEA) is not known. DHEA- 3 beta-sulfate fd(DHEA-S) is shown to induce a liver peroxisome proliferative response in rats in vivo at a dose at which DHEA is much less active, which is consistent with cultured hepatocyte studies indicating a requirement for sulfation for the activation of DHEA. Transient transfection experiments demonstrated that in contrast to the prototypic foreign chemical peroxisome proliferator pirinixic acid, DHEA-S and its 17 beta-reduced metabolite, 5-androstene-3 beta, 17 beta- diol-3 beta-sulfate, are inactive in mediating trans-activation by PPAR alpha in COS-1 cells. Two other mammalian PPAR isoforms, gamma and delta/Nucl, were also inactive with respect to DHEA-S trans-activation. To test whether PPAR alpha mediates peroxisomal gene induction by DHEA- S in intact animals, we administered DHEA-S or clofibrate to mice lacking a functional PPAR alpha gene. Both peroxisome proliferators markedly increased hepatic expression of two microsomal cytochrome P450 4A proteins as well as six mRNAs known to be associated with the peroxisomal proliferative response in wild-type mice. In contrast, neither DHEA-S nor clofibrate induced these hepatic proteins and mRNAs in PPAR alpha-deficient mice. Clofibrate-induced expression of kidney CYP4A mRNAs was also blocked in the PPAR alpha gene knockout mice. Thus, despite its unresponsiveness to steroidal peroxisome proliferators in transfection assays, PPAR alpha is obligatory for DHEA- S-stimulated hepatic peroxisomal gene induction. DHEA-S, or one of its metabolites, may thus serve as an important endogenous regulator of liver peroxisomal enzyme expression via a PPAR alpha-mediated pathway.
This article has been cited by other articles:
|
|
 |
|
  V. Tamasi, K. K. M. Miller, S. L. Ripp, E. Vila, T. E. Geoghagen, and R. A. Prough Modulation of Receptor Phosphorylation Contributes to Activation of Peroxisome Proliferator Activated Receptor {alpha} by Dehydroepiandrosterone and Other Peroxisome Proliferators Mol. Pharmacol., March 1, 2008; 73(3): 968 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kohalmy, V. Tamasi, L. Kobori, E. Sarvary, J.-M. Pascussi, P. Porrogi, D. Rozman, R. A. Prough, U. A. Meyer, and K. Monostory Dehydroepiandrosterone Induces Human CYP2B6 through the Constitutive Androstane Receptor Drug Metab. Dispos., September 1, 2007; 35(9): 1495 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Villareal and J. O. Holloszy DHEA enhances effects of weight training on muscle mass and strength in elderly women and men Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1003 - E1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Formoso, H. Chen, J.-a Kim, M. Montagnani, A. Consoli, and M. J. Quon Dehydroepiandrosterone Mimics Acute Actions of Insulin to Stimulate Production of Both Nitric Oxide and Endothelin 1 via Distinct Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase-Dependent Pathways in Vascular Endothelium Mol. Endocrinol., May 1, 2006; 20(5): 1153 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Villareal and J. O. Holloszy Effect of DHEA on Abdominal Fat and Insulin Action in Elderly Women and Men: A Randomized Controlled Trial JAMA, November 10, 2004; 292(18): 2243 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Howroyd, C. Swanson, C. Dunn, R. C. Cattley, and J. C. Corton Decreased Longevity and Enhancement of Age-Dependent Lesions in Mice Lacking the Nuclear Receptor Peroxisome Proliferator-Activated Receptor {alpha} (PPAR{alpha}) Toxicol Pathol, August 1, 2004; 32(5): 591 - 599. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Iwasaki, M. Asai, M. Yoshida, T. Nigawara, M. Kambayashi, and N. Nakashima Dehydroepiandrosterone-Sulfate Inhibits Nuclear Factor-{kappa}B-Dependent Transcription in Hepatocytes, Possibly through Antioxidant Effect J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3449 - 3454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Riddick, C. Lee, A. Bhathena, Y. E. Timsit, P.-Y. Cheng, E. T. Morgan, R. A. Prough, S. L. Ripp, K. K. M. Miller, A. Jahan, et al. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS Drug Metab. Dispos., April 1, 2004; 32(4): 367 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Ripp, K. C. Falkner, M. L. Pendleton, V. Tamasi, and R. A. Prough Regulation of CYP2C11 by Dehydroepiandrosterone and Peroxisome Proliferators: Identification of the Negative Regulatory Region of the Gene Mol. Pharmacol., July 1, 2003; 64(1): 113 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gu, S. L. Ripp, R. A. Prough, and T. E. Geoghegan Dehydroepiandrosterone Affects the Expression of Multiple Genes in Rat Liver Including 11beta -Hydroxysteroid Dehydrogenase Type 1: A cDNA Array Analysis Mol. Pharmacol., March 1, 2003; 63(3): 722 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kajita, T. Ishizuka, T. Mune, A. Miura, M. Ishizawa, Y. Kanoh, Y. Kawai, Y. Natsume, and K. Yasuda Dehydroepiandrosterone Down-Regulates the Expression of Peroxisome Proliferator-Activated Receptor {gamma} in Adipocytes Endocrinology, January 1, 2003; 144(1): 253 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Ripp, J. L. Fitzpatrick, J. M. Peters, and R. A. Prough Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor Drug Metab. Dispos., May 1, 2002; 30(5): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Akiyama, C. J. Nicol, C. Fievet, B. Staels, J. M. Ward, J. Auwerx, S. S. T. Lee, F. J. Gonzalez, and J. M. Peters Peroxisome Proliferator-activated Receptor-alpha Regulates Lipid Homeostasis, but Is Not Associated with Obesity. STUDIES WITH CONGENIC MOUSE LINES J. Biol. Chem., October 12, 2001; 276(42): 39088 - 39093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. C. Yen Dehydroepiandrosterone sulfate and longevity: New clues for an old friend PNAS, July 17, 2001; 98(15): 8167 - 8169. [Full Text] [PDF]
|
|
|
|
|
|
R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine, et al. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors Drug Metab. Dispos., April 13, 2001; 29(5): 623 - 633. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Portilla, G. Dai, J. M. Peters, F. J. Gonzalez, M. D. Crew, and A. D. Proia Etomoxir-induced PPARalpha -modulated enzymes protect during acute renal failure Am J Physiol Renal Physiol, April 1, 2000; 278(4): F667 - F675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Giguère Orphan Nuclear Receptors: From Gene to Function Endocr. Rev., October 1, 1999; 20(5): 689 - 725. [Abstract] [Full Text]
|
|
|
|
|
|
D. W. Singleton, X.-D. Lei, S. J. Webb, R. A. Prough, and T. E. Geoghegan Cytochrome P-450 mRNAs Are Modulated by Dehydroepiandrosterone, Nafenopin, and Triiodothyronine Drug Metab. Dispos., February 1, 1999; 27(2): 193 - 200. [Abstract] [Full Text]
|
|
|
|
|
|
Y.-C. Zhou and D. J. Waxman Cross-talk between Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) and Peroxisome Proliferator-activated Receptor-alpha (PPARalpha ) Signaling Pathways. GROWTH HORMONE INHIBITION OF PPARalpha TRANSCRIPTIONAL ACTIVITY MEDIATED BY STAT5b J. Biol. Chem., January 29, 1999; 274(5): 2672 - 2681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Poynter and R. A. Daynes Peroxisome Proliferator-activated Receptor alpha Activation Modulates Cellular Redox Status, Represses Nuclear Factor-kappa B Signaling, and Reduces Inflammatory Cytokine Production in Aging J. Biol. Chem., December 4, 1998; 273(49): 32833 - 32841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Wiesenberg, M. Chiesi, M. Missbach, C. Spanka, W. Pignat, and C. Carlberg Specific Activation of the Nuclear Receptors PPARgamma and RORA by the Antidiabetic Thiazolidinedione BRL 49653 and the Antiarthritic Thiazolidinedione Derivative CGP 52608 Mol. Pharmacol., June 1, 1998; 53(6): 1131 - 1138. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. Jones, X. Ding, and R. A. Daynes Nuclear Receptor Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Is Expressed in Resting Murine Lymphocytes. THE PPARalpha IN T AND B LYMPHOCYTES IS BOTH TRANSACTIVATION AND TRANSREPRESSION COMPETENT J. Biol. Chem., February 22, 2002; 277(9): 6838 - 6845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi, N. Tsuboyama-Kasaoka, T. Nakatani, M. Ishii, S. Tsutsumi, H. Aburatani, and O. Ezaki Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production Am J Physiol Gastrointest Liver Physiol, February 1, 2002; 282(2): G338 - G348. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
